Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
03/2005
03/31/2005US20050070508 Modulators of receptor kinases such as VEGFR; treating cancer, benign hyperplasia; 6-[2-(1-Methyl-1H-imidazol-2-yl)-thieno[3,2-b]pyridin-7-yloxy]-naphthalene-1-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide for example
03/31/2005US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response
03/31/2005US20050069551 cytotoxic compound, such as 3,5-bis(2-fluorobenzylidene)piperidin-4-one acetate bonded to protein; antitumor agents; anticarcinogenic agents; restenosis; antiarthritic agents;antiinflammatory agents
03/31/2005CA2540329A1 2-pyridinone derivatives, having hiv inhibiting properties
03/31/2005CA2539165A1 Cinnamoyl compound and use of the same
03/31/2005CA2539162A1 Cinnamoyl derivatives and use thereof
03/31/2005CA2538960A1 Cinnamoyl compound and use of the same
03/31/2005CA2521811A1 Haloalkyl containing compounds as cysteine protease inhibitors
03/30/2005EP1517975A2 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use
03/30/2005EP1517898A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases
03/30/2005EP1517894A1 N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin antagonists and/or serotonin reuptake inhibitors
03/30/2005EP1517882A1 Amide linker peroxisome proliferator activated receptor modulators
03/30/2005EP1517879A1 Aminoalkylphenols, methods of using and making the same
03/30/2005EP1517680A1 Benzoic acid derivatives as modulators of ppar alpha and gamma
03/30/2005EP1444197B1 Novel phenyl-propargylether derivatives
03/30/2005EP1294482B1 Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins
03/30/2005EP1235788B1 Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties
03/30/2005EP1224163B1 Use of carbonylamino derivatives against cns disorders
03/30/2005EP1192127B1 Substituted benzamide inhibitors of rhinovirus 3c protease
03/30/2005EP1147086B1 Compositions for the treatment of skin diseases
03/30/2005EP1047674B1 Process for production of donepezil derivatives
03/30/2005EP0877740B1 Thiol derivatives with metallopeptidase inhibitory activity
03/30/2005CN1602344A Electroluminescent platinum compounds and devices made with such compounds
03/30/2005CN1602314A Copper deposition method using copper formate complexes
03/30/2005CN1602313A 铑和铱的络合物 Complexes of rhodium and iridium
03/30/2005CN1602311A Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible NO-synthase
03/30/2005CN1602300A Process for the preparation of an enantiomerically enriched thio compound
03/30/2005CN1602298A Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens
03/30/2005CN1602194A Method for treating retroviral infections
03/30/2005CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
03/30/2005CN1194968C Aromatic tetramine compound containing pyridine strure and preparation method and use thereof
03/30/2005CN1194967C Heterocyclic ring contained methylamine cyanoacrylate compound and weeding activity
03/29/2005US6872852 Polyamine analogues as cytotoxic agents
03/29/2005US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents
03/29/2005US6872850 Inhibiting secretion of proteins encoded by adenosine uridylate-rich messenger RNAs, e.g. tumor necrosis factor, interleukin, interferon, cyclooxygenase-1 and -2 by administering a mono- or bisguanylhydrazones
03/29/2005US6872741 Sodium channel modulators
03/29/2005US6872719 Antiinflammatory agents; autoimmune disease
03/29/2005US6872690 Spraying on plants, environment
03/29/2005CA2176042C Alpha-aryl or heteroaryl-substituted amide ester acat inhibitors
03/29/2005CA2155214C Method for preparing 3-amino-2-chloro-4-alkylpyridine or -4-arylpyridine
03/24/2005WO2005026124A1 2-pyridone derivatives as netrophil elastase inhibitors and their use
03/24/2005WO2005026123A1 2-pyridone derivatives as neutrophil elastase inhibitors and their use
03/24/2005WO2005026095A1 Process for the preparation of roflumilast
03/24/2005WO2005025555A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
03/24/2005WO2005012220A3 Cycloalkylidene compounds as modulators of estrogen receptor
03/24/2005WO2005005389A3 Malonamide derivatives
03/24/2005WO2005003101A3 Pyrazine and pyridine derivatives as rho kinase inhibitors
03/24/2005WO2004106293A3 Oxazolyl - and thiazolyl - purine based tricyclic compounds.
03/24/2005WO2004096135A3 Inhibitors of akt activity
03/24/2005WO2004089922A3 Calcium channel inhibitors comprising benzhydril spaced from piperazine
03/24/2005WO2004085384A8 Bis-aryl sulfonamides
03/24/2005WO2004064730A3 Compounds, compositions and methods
03/24/2005WO2004060882A8 Cb 1/cb 2 receptor ligands and their use in the treatment of pain
03/24/2005WO2004046113A3 Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors
03/24/2005WO2004039795A3 Amide compounds for the treatment of hyperlipidemia
03/24/2005WO2003080576A8 Pyridinyl amides and compositions thereof for use as fungicides
03/24/2005US20050065353 Mitosis agents; antitumor agents; anticancer agents
03/24/2005US20050065347 Short synthesis of pyridine-based pharmaceutical intermediates
03/24/2005US20050065346 anticoagulants; thrombosis; factor x inhibitor
03/24/2005US20050065339 Amino-alkyl derivatives
03/24/2005US20050065304 Monomer having rotaxane structure and polymers and processes for production of both
03/24/2005US20050065193 Carbamates of 2-heterocyclic-1,2-ethanediols
03/24/2005US20050065188 Aryl or heteroaryl amide compounds
03/24/2005US20050065174 Novel chain-breaking antioxidants
03/24/2005US20050065162 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
03/24/2005US20050065155 Autoimmune disease ; antiinflammatory agents; antiischemic agents; rheumatic diseases; antiarthritic agents
03/24/2005US20050065095 Antibacterial agents
03/24/2005US20050065033 Method to inhibit ethylene responses in plants
03/24/2005US20050065032 E.g 2-(5-chloro-3-pyridyloxy)-N-(2-methylpent-3-yn-2-yl)butyramide; 2-(5chloro-3-pyridyloxy)-N-(4methylhex-2-yn-4-yl)butyramide; 2-(5chloro-3-pyridyloxy)-N-(2-methylpent-3-yn-2-yl)valeramide
03/24/2005US20050060814 Novel 6-alkoxy-2,3-diaminopyridine couplers in which the amino radical in position 2 is a monosubstituted amino radical, and use of these couplers for dyeing keratin fibres
03/24/2005DE10341864B4 Verfahren zur Herstellung hochreiner 2,3-Pyridindicarbonsäure A method for producing highly pure 2,3-pyridine dicarboxylic acid
03/24/2005CA2538410A1 2-pyridone derivatives as netrophil elastase inhibitors and their use
03/23/2005EP1516877A1 Amine derivatives as protease inhibitors
03/23/2005EP1516875A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
03/23/2005EP1516874A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
03/23/2005EP1516873A1 2-pyridinone derivatives, having HIV inhibiting properties
03/23/2005EP1516033A1 Method for producing highly pure tris-ortho metalated organoiridium compounds
03/23/2005EP1516021A1 Printing process using specified azo compounds
03/23/2005EP1515951A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors
03/23/2005EP1515944A1 Aspartyl protease inhibitors
03/23/2005EP1515941A1 2-naphthamide derivatives
03/23/2005EP1515940A2 Aminoalkoxy-functional chalcones
03/23/2005EP1515726A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors
03/23/2005EP1098647B1 Compounds and compositions for treating tissue ischemia
03/23/2005CN1599788A Organic compounds
03/23/2005CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/23/2005CN1599723A Pyridyloxyalkanoic acid amide derivatives useful as fungicides
03/23/2005CN1597668A Biamido heterocyclic derivative with antitumour activity and its preparation method and use
03/23/2005CN1193788C Beta 2-adrenergic receptor agonist
03/22/2005US6870058 Polyhydroxy, dienyl lactones and intermediates
03/22/2005US6870056 Substitituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
03/22/2005US6870021 Mixtures of condensation polymers comprising organonitrogen or organosulfur polymers and curing agents, having preferential binding, used for analysis, separation and resolution of racemic mixtures
03/22/2005US6869975 Linked biaryl compounds
03/22/2005US6869966 N-substituted-2-oxodihydropyridine derivatives
03/22/2005US6869953 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
03/22/2005US6869904 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom
03/22/2005US6869605 Anticarcinogenic agents
03/22/2005US6869590 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque
03/22/2005CA2257772C Bicyclic¬3.1.0|hexanes and related compounds
03/22/2005CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same
1 ... 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 ... 633